Clinical
Research roundup
Debbie Rigby rounds up the latest in research news Risk of gastrointestinal bleeding by specific SSRIs and SNRIs A systematic review of 20 studies has concluded all selective serotonin reuptake …
No ‘one-size-fits-all’ approach
Q&A: We speak with senior pharmacist and researcher Hana Amer about her recent scoping study on collaborative prescribing, the different models and benefits for patients Adelaide University PhD candidate and …
Gender impacts pharmacists’ response to patients at risk of suicide
Community pharmacists take men more seriously than women when they are perceived to be at risk of suicide, a study reveals Pharmacists need to be trained to recognise their potential unconscious biases to better …
Bisoprolol ‘safe’ in COPD patients: study
RCT results show the cardio-selective beta-blocker is no longer contraindicated in this patient population, says lead Bisoprolol can be safely used in people with chronic obstructive pulmonary disease (COPD), according …
Telehealth tied to lower antibiotic prescribing
Do doctors feel more pressure to prescribe antibiotics in face-to-face settings? Australian researchers investigated GPs who frequently used telehealth wrote fewer antibiotic scripts than their professional peers, an Australian study …
The top 12: Clinical News
Weight loss treatments and medicine shortages dominated our readers clinical news interests in 2025, alongside stories on vaping, triple therapies and contraception These were the most read clinical news stories …
January MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Faecal microbiota (Biomictra) works via restoration of gut microbial diversity. Biomictra is indicated …
A boost to coverage
Shingrix addition to NIP boosted uptake by 40%, finds leading research centre Shingles vaccination coverage increased by 40% among adults aged ≥65 years in the first 12 months after Shingrix …
Extra time for Telstra Health to meet eNRMC conformance
Concerns over the potential clinical risks around shifting patients from Telstra Health’s MedPoint medication charts to a paper-based system behind extension to conformance deadline Telstra Health has been given until April …
Research Roundup
Debbie Rigby rounds up the latest in research news Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome A systematic review and meta-analysis of 11 RCTs has concluded that …
Scheduling change for adrenaline product
Intranasal adrenaline soon to become Pharmacist Only for treating anaphylaxis The Therapeutic Goods Administration has decided to downschedule intranasal preparations containing 2% or less of adrenaline to Pharmacist Only (Schedule …
December MIMS Update
Some of the recent changes to the medicines landscape, with new indications and contraindications New Indications Durvalumab (Imfinzi) in combination with gemcitabine and cisplatin is now also indicated as neoadjuvant …